These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30509939)

  • 1. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants.
    Tang BH; Wu YE; Kou C; Qi YJ; Qi H; Xu HY; Leroux S; Huang X; Zhou Y; Zheng Y; Jacqz-Aigrain E; Shen AD; Zhao W
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants.
    Wu YE; Wang YK; Tang BH; Dong L; Li X; Zhang W; Li DF; Tian LY; van den Anker J; You DP; Zhao W
    J Clin Pharmacol; 2021 Apr; 61(4):538-546. PubMed ID: 32996155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.
    Li X; Qi H; Jin F; Yao BF; Wu YE; Qi YJ; Kou C; Wu XR; Luo XJ; Shen YH; Zheng X; Wang YH; Xu F; Jiao WW; Li JQ; Xiao J; Dong YN; Du B; Shi HY; Xu BP; Shen AD; Zhao W
    Eur J Pharm Sci; 2021 Aug; 163():105868. PubMed ID: 33951483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
    Zhao W; Hill H; Le Guellec C; Neal T; Mahoney S; Paulus S; Castellan C; Kassai B; van den Anker JN; Kearns GL; Turner MA; Jacqz-Aigrain E;
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6572-80. PubMed ID: 25155587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants.
    Zhou J; Jiang L; Zhang ZL; Wang ZR; Zhang YX; Lin X; Tang BH; Yao BF; Guo ZX; Yang JJ; Van Den Anker J; Wu YE; Zhao W
    J Antimicrob Chemother; 2022 Jul; 77(8):2238-2244. PubMed ID: 35662337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants.
    Qi H; Kou C; Qi YJ; Tang BH; Wu YE; Jin F; Luo XJ; Shen YH; Guo YJ; Qi X; Wang YC; Dong Q; Chen XK; Shi HY; Zheng Y; Zhao W; Shen AD
    Int J Antimicrob Agents; 2019 Mar; 53(3):347-351. PubMed ID: 30472290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Kontou A; Sarafidis K; Begou O; Gika HG; Tsiligiannis A; Ogungbenro K; Dokoumetzidis A; Agakidou E; Roilides E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants.
    Zhao Y; Yao BF; Kou C; Xu HY; Tang BH; Wu YE; Hao GX; Zhang XP; Zhao W
    Front Pharmacol; 2020; 11():14. PubMed ID: 32116695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amoxicillin levels in young infants (0-59 days) with sepsis treated with oral amoxicillin.
    Mir F; Pearce RE; Baig-Ansari N; Qazi S; Barrett JS; Abdel-Rahman S; Kearns G; Zaidi AK
    Arch Dis Child; 2020 Dec; 105(12):1208-1214. PubMed ID: 32404437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.
    Pullen J; Stolk LM; Nieman FH; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Apr; 28(2):226-31. PubMed ID: 16628135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study.
    Keij FM; Schouwenburg S; Kornelisse RF; Preijers T; Mir F; Degraeuwe P; Stolk LM; van Driel A; Kenter S; van der Sluijs J; Heidema J; den Butter PCP; Reiss IKM; Allegaert K; Tramper-Stranders GA; Koch BCP; Flint RB
    Clin Infect Dis; 2023 Nov; 77(11):1595-1603. PubMed ID: 37757471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic Analysis.
    Wang YK; Wu YE; Li X; Tian LY; Khan MW; Tang BH; Shi HY; Zheng Y; Hao GX; van den Anker J; You DP; Zhao W
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of amoxicillin in neonates during continuous intravenous infusion.
    van Boekholt A; Fleuren H; Mouton J; Kramers C; Sprong T; Gerrits P; Semmekrot B
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):1007-12. PubMed ID: 27039340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Dosing Considerations for Gentamicin in Newborns with Suspected or Proven Sepsis Caused by Gram-Negative Bacteria.
    Bijleveld YA; van den Heuvel ME; Hodiamont CJ; Mathôt RA; de Haan TR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxicillin pharmacokinetics in (preterm) infants aged 10 to 52 days: effect of postnatal age.
    Pullen J; Driessen M; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
    Ther Drug Monit; 2007 Jun; 29(3):376-80. PubMed ID: 17529898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.
    Germovsek E; Osborne L; Gunaratnam F; Lounis SA; Busquets FB; Standing JF; Sinha AK
    J Antimicrob Chemother; 2019 Apr; 74(4):1003-1011. PubMed ID: 30668696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants.
    Shi ZR; Chen XK; Tian LY; Wang YK; Zhang GY; Dong L; Jirasomprasert T; Jacqz-Aigrain E; Zhao W
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.